You searched for "blindness"

791 results found

Governments missing opportunity to increase economic progress

Report calls on governments to invest in eye health to address $410.​​​9​​ billion loss in economic productivity.

Edinburgh local plans to run Scottish half marathon for Fight for Sight

A local to Edinburgh and East Lothian who suffers from Stargardts disease will run the Scottish half marathon to fundraise for Fight for Sight.

Effects of ML4 on the eye

Mucolipidosis type IV (ML4) is an autosomal recessive lysosomal storage disease and is caused by variants of the MC0LN1 gene. It often presents in young individuals with eye and ocular adnexa issues. The authors present a case report and literature...

In conversation with Yasmin El-Rouby

Author and Eye Doctor, Dr Yasmin El-Rouby, wishes to raise awareness about common vision disorders. Envisioning a world where preventable eye conditions are caught early, she founded Baseera, a non-profit organisation, to improve access to basic eyecare in developing countries....

Orbis and FundamentalVR to talk at 100% Optical

The health care technology company teams up with the global non-profit to showcase how simulation, telemedicine and virtual reality (VR) are changing the landscape of cataract surgery education.

Glaucoma UK and The Royal College of Ophthalmologists announce research award 2024

Glaucoma UK and The Royal College of Ophthalmologists are collaborating to run this prestigious award which has previously funded a range of research topics from prospective stem cell treatments to the use of big data in patient risk stratification.

Transfected RPE cells inhibit AMD in rats

Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly. Wet AMD is characterised by choroidal neovascularisation, new vessels into the retina, leading to leakage and tissue damage. Many proangiogenic factors particularly vascular endothelial growth factor (VEGF)...

Outcomes of ‘treat and extend’ for neovascular AMD

The authors report on 24-month outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy using a ‘treat and extend’ regime for treatment-naïve neovascular age-related macular degeneration (nAMD). Data for this study was collected from the Fight Retinal Blindness observational registry based...

IN FOCUS - Beyond 2020: what next for global eye health?

The year 2020 is a pivotal year for global eye health. It marks the conclusion of ‘VISION 2020: The Right to Sight’ which has guided action for the past two decades, and the end of the World Health Organization (WHO)...

Making a life-changing difference in Bangladesh

It has always been a desire of mine to volunteer in a ‘vision aid’ type project abroad, but due to various factors I had not been able to fulfil this desire until very recently. A gentleman called Mizanur Rahman (founder...

Orbis and FedEx team up on three-week training for Eye Care Professionals in Vietnam

This is the first surgical project for the Orbis Flying Eye Hospital in three years.

Understanding the inequalities of ophthalmic care for Indigenous people in a first world country

Aboriginal Australians have faced numerous challenges over the past centuries. Here in this article, Edward Saxton highlights why there are inequalities of ophthalmic care in Australia and why this has led to increased levels of blindness in Aboriginal people relative...